封面
市场调查报告书
商品编码
1726384

全球微阵列市场:市场规模、份额、趋势分析(按产品/服务、类型、最终用途和地区)、细分市场预测(2025-2030 年)

Microarray Market Size, Share & Trends Analysis Report By Product And Services (Instruments, Consumables), By Type, By Application (Drug Discovery, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

微阵列市场的成长与趋势:

根据Grand View Research, Inc.的最新报告,全球微阵列市场预计到2030年将达到84.6亿美元,2025年至2030年的复合年增长率为5.48%。

市场驱动因素包括全球癌症患者数量的增加以及微阵列在定序、基因组图谱和个人化医疗中的广泛应用。此外,增加全球研发投资也是推动成长的关键,因为这将导致微阵列在研究目的中的使用增加,从而促进和改善医疗保健。

微阵列具有广泛的应用,包括研究、药物发现、疾病诊断、基因组和蛋白质组学研究、植物和食品研究以及农业研究。根据美国神经病学会发表的报告,染色体微阵列分析可用于诊断智能障碍和菌丛失调,该测试也被推荐为第一线诊断测试。蛋白质体学和基因组学的最新进展,加上人类基因序列测定,正在增加筛检药物标靶的数量。 《美国国家科学院院刊》(PNAS)上发表的一份报告开发了用于高通量毒理学检测的微型3D细胞培养微阵列。

主要企业推出不同类型的阵列平台也是预期会增加市场潜力的因素。例如,生物製品公司 R&D Systems 提供 Proteome Profiler Antibody Array,这是一种用于测量单一样本中 119 多种蛋白质的蛋白质微阵列。使用该产品,实验室技术人员不需要专门的设备,也不需要进行Western blot实验。

近年来,大型市场参与者与中小型企业合作,扩大现有的产品系列和地理影响力。例如,2018年,默克公司与HistoCyte Laboratories Ltd.签署协议,在美国和其他地区销售细胞微阵列,为研究人员提供一种经济高效且简单的选择。

由于主要企业对微阵列的核准不断增加,预计亚太地区在预测期内将出现良好的成长。例如,2015年,安捷伦科技公司的SureScan Dx微阵列扫描器获得了中国FDA的批准。由于推出改善疾病诊断的新产品,中东和非洲地区预计也将出现庞大的商机。例如,2017 年,赛默飞世尔科技公司推出了 Axiom Africa 阵列。该阵列捕捉了非洲人群以及欧洲和亚洲人群的基因组范围变异。

微阵列市场报告重点

  • 预计到 2024 年,消耗品将占据最大的市场占有率,达到 49.73%。分子诊断和研究应用对自动化、精确度和可扩展性的需求不断增加,预计将推动仪器仪表领域在预测期内以最快的速度成长。
  • 2024 年,DNA 微阵列将占据最大的收益占有率。由于蛋白质微阵列在药物发现、免疫分析和生物标记检验的应用日益广泛,预计在预测期内将以最快的速度成长。
  • 2024 年的微阵列市场将以研究应用为主导,这得益于基因体学、蛋白质体学和生物医学创新投资的增加。预计疾病诊断在预测期内将以最快的速度成长。
  • 2024 年,研究和学术机构占据了最大的市场收益占有率。预计诊断实验室部门在预测期内将以最快的复合年增长率成长。
  • 北美微阵列市场在全球产业中占据主导地位,2024 年的市占率为 48.27%。由于研发活动投资的增加,亚太微阵列市场预计将显着成长。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 微阵列市场:驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 微阵列市场:分析工具
    • 产业分析:波特五力分析
    • PESTEL分析

第四章 微阵列市场:依产品和服务的估计和趋势分析

  • 按产品/服务分類的市场占有率(2023 年和 2030 年)
  • 细分仪表板
  • 全球微阵列市场(按产品和服务)展望
  • 市场规模预测及趋势分析(2018-2030年)
    • 耗材
    • 装置
    • 软体与服务

第五章 微阵列市场:按类型估计和趋势分析

  • 按类型分類的市场占有率(2023 年和 2030 年)
  • 细分仪表板
  • 全球微阵列市场展望(按类型)
  • 市场规模预测及趋势分析(2018-2030年)
    • DNA微阵列
    • 蛋白质微阵列
    • 其他的

第六章 微阵列市场:按应用的估计和趋势分析

  • 按应用分類的市场占有率(2023 年和 2030 年)
  • 细分仪表板
  • 全球微阵列市场应用展望
  • 市场规模预测及趋势分析(2018-2030年)
    • 研究用途
    • 药物研发
    • 疾病诊断
    • 其他用途

第七章微阵列市场:依最终用途的估计和趋势分析

  • 按最终用途分類的市场占有率(2023 年和 2030 年)
  • 细分仪表板
  • 全球微阵列市场(依最终用途)展望
  • 市场规模预测及趋势分析(2018-2030年)
    • 研究和学术机构
    • 製药和生物技术公司
    • 诊断实验室
    • 其他的

第八章 微阵列市场:区域估计与趋势分析

  • 各地区市场占有率分析(2023 年及 2030 年)
  • 市场仪表板:按地区
  • 全球市场概况:按地区
  • 市场规模预测及趋势分析(2018-2030年)
  • 北美洲
    • 北美:SWOT分析
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲:SWOT分析
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区:SWOT分析
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲:SWOT分析
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲:SWOT分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 主要客户
    • 主要企业市场占有率分析(2023年)
    • Thermo Fisher Scientific Inc(Applied Biosystems)
    • Agilent Technologies, Inc
    • Illumina, Inc
    • PerkinElmer
    • Schott(Applied Microarrays)
    • Danaher Corporation
    • Arrayit Corporation
    • Bio-Rad Laboratories, Inc
    • Microarrays Inc
Product Code: GVR-3-68038-965-4

Microarray Market Growth & Trends:

The global microarray market size is expected to reach USD 8.46 billion by 2030, registering a CAGR of 5.48% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market drivers propelling market growth include a global rise in cancer cases and a wide range of applications of microarrays in sequencing, genome mapping, personalized medicines, and others. A rise in global R&D investments is also key in propelling growth as this would lead to a rise in the use of microarrays for research purposes to advance and improve in healthcare.

Microarrays have a wide range of applications such as research applications, drug discovery, disease diagnosis, genomic and proteomic research, plant and food research, agricultural research, among other applications. According to a report published by the American Academy of Neurology, chromosomal microarray analysis can be used to diagnose intellectual disabilities and disomic features, this test has also been recommended as a first line diagnostic test. Recent advances in proteomics and genomics coupled with human genome sequencing have led to an increase in several screenable drug targets. According to a report published by PNAS (Proceedings of the National Academy of Sciences of the United States of America), a miniature 3D cell culture microarray has been developed for high throughput toxicological assays.

The introduction of various types of array platforms offered by leading companies is also another factor anticipated to boost market potential. For instance, R&D Systems, a biological products company offers proteome profiler antibody array, a protein microarray used to measure over 119 proteins in one sample. With the use of this product, laboratory technicians do not need any specialized equipment additionally eliminating the need for western blot experiments.

In recent years, large scale market players have collaborated with small and medium scale companies to expand their existing product portfolio and geographical presence. For instance, in 2018, Merck signed an agreement with HistoCyte Laboratories Ltd., to distribute cell microarrays in the U.S. and other geographies thereby, facilitating researchers with a cost-effective and easy option.

The Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising regulatory approvals received by leading companies for microarrays. For instance, in 2015, Agilent Technologies Inc. received the China FDA approval for its SureScan Dx microarray scanner. The Middle East & African region is also anticipated to showcase immense opportunities due to the launch of new products in the region to improve the diagnosis of diseases. For instance, in 2017, Thermo Fisher Scientific, Inc. launched Axiom Africa array, this array captures genome-wide variation in African populations as well as in Europe and Asian populations.

Microarray Market Report Highlights:

  • Consumables held the largest market share of 49.73% in 2024. Instruments are expected to grow at the fastest rate over the forecast period, driven by the increasing demand for automation, precision, and scalability in molecular diagnostics and research applications.
  • DNA microarrays accounted for the largest revenue share in 2024. Protein microarrays are expected to grow at the fastest rate over the forecast period, owing to their increasing use in drug discovery, immune profiling, and biomarker validation.
  • The research applications segment dominated the microarray market in 2024, supported by increasing investments in genomics, proteomics, and biomedical innovation. The disease diagnostics segment is anticipated to grow at the fastest rate over the forecast period.
  • Research and academic institutes accounted for the largest revenue share of the market in 2024. The diagnostic laboratories segment is expected to grow at the fastest CAGR during the forecast period.
  • North America microarray market dominated the global industry and accounted for a 48.27% share in 2024. The microarray market in Asia Pacific is anticipated to witness significant growth, driven by the increasing investment in research and development activities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product and Services
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and Services Outlook
    • 2.2.2. Type Outlook
    • 2.2.3. Application Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microarray Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for personalized medicine and genomic research
      • 3.2.1.2. Technological advancements in microarray platforms
      • 3.2.1.3. Expanding applications in diagnostics and infectious disease testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of microarray instruments and consumables
  • 3.3. Microarray Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Microarray Market: Product and Services Estimates & Trend Analysis

  • 4.1. Product and Services Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Microarray Market by Product and Services Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Consumables
      • 4.4.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Software and Services
      • 4.4.3.1. Software and services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Microarray Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Microarray Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. DNA Microarray
      • 5.4.1.1. DNA Microarray market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Protein Microarray
      • 5.4.2.1. Protein microarray market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Microarray Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Microarray Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Research applications
      • 6.4.1.1. Research application market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Drug discovery
      • 6.4.2.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Disease diagnostics
      • 6.4.3.1. Disease diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others applications
      • 6.4.4.1. Others application market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Microarray Market: End use Estimates & Trend Analysis

  • 7.1. End use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Microarray Market by End use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Research and Academic Institutes
      • 7.4.1.1. Research and Academic Institutes market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Pharmaceutical and Biotechnology Companies
      • 7.4.2.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Diagnostic Laboratories
      • 7.4.3.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Microarray Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. North America: SWOT Analysis
    • 8.5.2. U.S.
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe: SWOT Analysis
    • 8.6.2. UK
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Spain
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Norway
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Sweden
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.9. Denmark
      • 8.6.9.1. Key country dynamics
      • 8.6.9.2. Regulatory framework
      • 8.6.9.3. Competitive scenario
      • 8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific: SWOT Analysis
    • 8.7.2. Japan
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. Australia
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. South Korea
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Regulatory framework
      • 8.7.7.3. Competitive scenario
      • 8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America: SWOT Analysis
    • 8.8.2. Brazil
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA: SWOT Analysis
    • 8.9.2. South Africa
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key country dynamics
      • 8.9.5.2. Regulatory framework
      • 8.9.5.3. Competitive scenario
      • 8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Thermo Fisher Scientific Inc (Applied Biosystems)
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Services benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Agilent Technologies, Inc
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Services benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Illumina, Inc
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Services benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. PerkinElmer
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Services benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Schott (Applied Microarrays)
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Services benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Danaher Corporation
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Services benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Arrayit Corporation
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Services benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Bio-Rad Laboratories, Inc
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Services benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Microarrays Inc
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Services benchmarking
      • 9.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America microarray market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 4 North America microarray market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America microarray market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 8 U.S. microarray market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. microarray market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 12 Canada microarray market, by type, 2018 - 2030 (USD Million)
  • Table 13 Canada microarray market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 16 Mexico microarray market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico microarray market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe microarray market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 21 Europe microarray market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe microarray market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 25 Germany microarray market, by type, 2018 - 2030 (USD Million)
  • Table 26 Germany microarray market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 29 UK microarray market, by type, 2018 - 2030 (USD Million)
  • Table 30 UK microarray market, by application, 2018 - 2030 (USD Million)
  • Table 31 UK microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 33 France microarray market, by type, 2018 - 2030 (USD Million)
  • Table 34 France microarray market, by application, 2018 - 2030 (USD Million)
  • Table 35 France microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 37 Italy microarray market, by type, 2018 - 2030 (USD Million)
  • Table 38 Italy microarray market, by application, 2018 - 2030 (USD Million)
  • Table 39 Italy microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 41 Spain microarray market, by type, 2018 - 2030 (USD Million)
  • Table 42 Spain microarray market, by application, 2018 - 2030 (USD Million)
  • Table 43 Spain microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 45 Denmark microarray market, by type, 2018 - 2030 (USD Million)
  • Table 46 Denmark microarray market, by application, 2018 - 2030 (USD Million)
  • Table 47 Denmark microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Sweden microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 49 Sweden microarray market, by type, 2018 - 2030 (USD Million)
  • Table 50 Sweden microarray market, by application, 2018 - 2030 (USD Million)
  • Table 51 Sweden microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 53 Norway microarray market, by type, 2018 - 2030 (USD Million)
  • Table 54 Norway microarray market, by application, 2018 - 2030 (USD Million)
  • Table 55 Norway microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific microarray market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific microarray market, by type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific microarray market, by application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 62 China microarray market, by type, 2018 - 2030 (USD Million)
  • Table 63 China microarray market, by application, 2018 - 2030 (USD Million)
  • Table 64 China microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 66 Japan microarray market, by type, 2018 - 2030 (USD Million)
  • Table 67 Japan microarray market, by application, 2018 - 2030 (USD Million)
  • Table 68 Japan microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 70 India microarray market, by type, 2018 - 2030 (USD Million)
  • Table 71 India microarray market, by application, 2018 - 2030 (USD Million)
  • Table 72 India microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 73 South Korea microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 74 South Korea microarray market, by type, 2018 - 2030 (USD Million)
  • Table 75 South Korea microarray market, by application, 2018 - 2030 (USD Million)
  • Table 76 South Korea microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Australia microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 78 Australia microarray market, by type, 2018 - 2030 (USD Million)
  • Table 79 Australia microarray market, by application, 2018 - 2030 (USD Million)
  • Table 80 Australia microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 82 Thailand microarray market, by type, 2018 - 2030 (USD Million)
  • Table 83 Thailand microarray market, by application, 2018 - 2030 (USD Million)
  • Table 84 Thailand microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 86 Latin America microarray market, by type, 2018 - 2030 (USD Million)
  • Table 87 Latin America microarray market, by application, 2018 - 2030 (USD Million)
  • Table 88 Latin America microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Brazil microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 90 Brazil microarray market, by type, 2018 - 2030 (USD Million)
  • Table 91 Brazil microarray market, by application, 2018 - 2030 (USD Million)
  • Table 92 Brazil microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Argentina microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 94 Argentina microarray market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina microarray market, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 97 MEA microarray market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 99 MEA microarray market, by type, 2018 - 2030 (USD Million)
  • Table 100 MEA microarray market, by application, 2018 - 2030 (USD Million)
  • Table 101 MEA microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Africa microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 103 South Africa microarray market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Africa microarray market, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia microarray market, by type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia microarray market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 110 UAE microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 111 UAE microarray market, by type, 2018 - 2030 (USD Million)
  • Table 112 UAE microarray market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE microarray market, by end use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait microarray market, by product and services, 2018 - 2030 (USD Million)
  • Table 115 Kuwait microarray market, by type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait microarray market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait microarray market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Microarray: market outlook
  • Fig. 14 Microarray competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Microarray driver impact
  • Fig. 20 Microarray restraint impact
  • Fig. 21 Microarray strategic initiatives analysis
  • Fig. 22 Microarray: Product and Services movement analysis
  • Fig. 23 Microarray: Product and Services outlook and key takeaways
  • Fig. 24 Consumables market estimates and forecast, 2018 - 2030
  • Fig. 25 Instruments market estimates and forecast, 2018 - 2030
  • Fig. 26 Software and services market estimates and forecast, 2018 - 2030
  • Fig. 27 Microarray: Type movement analysis
  • Fig. 28 Microarray: Type outlook and key takeaways
  • Fig. 29 DNA microarray market estimates and forecasts, 2018 - 2030
  • Fig. 30 Protein microarray market estimates and forecasts,2018 - 2030
  • Fig. 31 Others market estimates and forecasts,2018 - 2030
  • Fig. 32 Microarray: Application movement analysis
  • Fig. 33 Microarray: application outlook and key takeaways
  • Fig. 34 Research applications market estimates and forecasts, 2018 - 2030
  • Fig. 35 Drug discovery market estimates and forecasts, 2018 - 2030
  • Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others applications market estimates and forecasts, 2018 - 2030
  • Fig. 38 Microarray: End use movement analysis
  • Fig. 39 Microarray: End use outlook and key takeaways
  • Fig. 40 Research and academic institutes market estimates and forecasts, 2018 - 2030
  • Fig. 41 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 42 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global microarray market: Regional movement analysis
  • Fig. 45 Global microarray market: Regional outlook and key takeaways
  • Fig. 46 Global microarray market shares and leading players
  • Fig. 47 North America
  • Fig. 48 North America market estimates and forecasts, 2018 - 2030
  • Fig. 49 U.S.
  • Fig. 50 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 51 Canada
  • Fig. 52 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 53 Mexico
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 55 Europe
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK
  • Fig. 58 UK market estimates and forecasts, 2018 - 2030
  • Fig. 59 Germany
  • Fig. 60 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 61 France
  • Fig. 62 France market estimates and forecasts, 2018 - 2030
  • Fig. 63 Italy
  • Fig. 64 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 65 Spain
  • Fig. 66 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 67 Denmark
  • Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 69 Sweden
  • Fig. 70 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 71 Norway
  • Fig. 72 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 73 Asia Pacific
  • Fig. 74 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 75 China
  • Fig. 76 China market estimates and forecasts, 2018 - 2030
  • Fig. 77 Japan
  • Fig. 78 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 79 India
  • Fig. 80 India market estimates and forecasts, 2018 - 2030
  • Fig. 81 Thailand
  • Fig. 82 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 83 South Korea
  • Fig. 84 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 85 Australia
  • Fig. 86 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 87 Latin America
  • Fig. 88 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 89 Brazil
  • Fig. 90 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 91 Argentina
  • Fig. 92 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 93 Middle East and Africa
  • Fig. 94 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 95 South Africa
  • Fig. 96 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 97 Saudi Arabia
  • Fig. 98 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 99 UAE
  • Fig. 100 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 101 Kuwait
  • Fig. 102 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 103 Market share of key market players- Microarray